Stable overexpression of native and artificial miRNAs for the production of differentially fucosylated antibodies in CHO cells.

CHO biopharmaceuticals biosimilar fucosylation engineering microRNA

Journal

Engineering in life sciences
ISSN: 1618-0240
Titre abrégé: Eng Life Sci
Pays: Germany
ID NLM: 101193313

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 08 08 2023
revised: 04 03 2024
accepted: 17 03 2024
medline: 7 6 2024
pubmed: 7 6 2024
entrez: 7 6 2024
Statut: epublish

Résumé

Cell engineering strategies typically rely on energy-consuming overexpression of genes or radical gene-knock out. Both strategies are not particularly convenient for the generation of slightly modulated phenotypes, as needed in biosimilar development of for example differentially fucosylated monoclonal antibodies (mAbs). Recently, transiently transfected small noncoding microRNAs (miRNAs), known to be regulators of entire gene networks, have emerged as potent fucosylation modulators in Chinese hamster ovary (CHO) production cells. Here, we demonstrate the applicability of stable miRNA overexpression in CHO production cells to adjust the fucosylation pattern of mAbs as a model phenotype. For this purpose, we applied a miRNA chaining strategy to achieve adjustability of fucosylation in stable cell pools. In addition, we were able to implement recently developed artificial miRNAs (amiRNAs) based on native miRNA sequences into a stable CHO expression system to even further fine-tune fucosylation regulation. Our results demonstrate the potential of miRNAs as a versatile tool to control mAb fucosylation in CHO production cells without adverse side effects on important process parameters.

Identifiants

pubmed: 38845814
doi: 10.1002/elsc.202300234
pii: ELSC1610
pmc: PMC11151017
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2300234

Informations de copyright

© 2024 The Authors. Engineering in Life Sciences published by Wiley‐VCH GmbH.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Patrick Schlossbauer (P)

Institute for Applied Biotechnology University of Applied Sciences Biberach Biberach Germany.

Lukas Naumann (L)

Department of Chemistry Aalen University Aalen Germany.

Florian Klingler (F)

Institute for Applied Biotechnology University of Applied Sciences Biberach Biberach Germany.

Madina Burkhart (M)

Institute for Applied Biotechnology University of Applied Sciences Biberach Biberach Germany.

René Handrick (R)

Institute for Applied Biotechnology University of Applied Sciences Biberach Biberach Germany.

Kathrin Korff (K)

Department of Chemistry Aalen University Aalen Germany.

Christian Neusüß (C)

Department of Chemistry Aalen University Aalen Germany.

Kerstin Otte (K)

Institute for Applied Biotechnology University of Applied Sciences Biberach Biberach Germany.

Friedemann Hesse (F)

Institute for Applied Biotechnology University of Applied Sciences Biberach Biberach Germany.

Classifications MeSH